XML 42 R28.htm IDEA: XBRL DOCUMENT v3.25.2
Capital (Tables)
 3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Summary of Common Shares Outstanding [Table Text Block]
Detailed below is a roll forward of the Company's common shares outstanding for the three-month periods ended March 31, 2025 and 2024 and the years ended December 31, 2024 and 2023:
Three-Month Period EndedYear Ended
March 31, 2025
March 31, 2024(1)
December 31, 2024December 31, 2023
(Unaudited)
Common Shares Outstanding (12/31/2024, 12/31/2023, 12/31/2023, and 12/31/2022, respectively)
29,651,553 18,601,464 18,601,464 13,377,840 
Share Activity:
Common shares issued8,075,118 1,218,146 10,964,023 5,183,037 
Restricted common shares issued— — 90,229 47,393 
Common shares repurchased(167,476)— — — 
Forfeiture of common shares to satisfy tax withholding obligations— — (4,163)(6,806)
Common Shares Outstanding (3/31/2025, 3/31/2024, 12/31/2024, 12/31/2023, respectively)
37,559,195 19,819,610 29,651,553 18,601,464 
Unvested restricted shares outstanding (3/31/2025, 3/31/2024, 12/31/2024, 12/31/2023, respectively)
39,577 53,448 62,729 53,448 
.
Vesting schedule for restricted shares [Table Text Block]
The below table provides details on the Company's restricted shares granted pursuant to share award agreements which are unvested at March 31, 2025:
Grant RecipientNumber of Restricted Shares GrantedGrant Date
Vesting Date(1)
Partially dedicated employees:
7,236 December 14, 2023December 14, 2025
17,350 December 20, 2024December 12, 2025
14,991 December 20, 2024December 12, 2026
(1)Date at which such restricted shares will vest and become non-forfeitable.